Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenza Conteduca

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
Cells|January 22, 2021
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate CancerVincenza Conteduca, Alessandra Mosca, Nicole Brighi, et al.
Translational Andrology and Urology|August 25, 2021
Epigenetics in prostate cancer: clinical implicationsVincenza Conteduca, Judy Hess, Yasutaka Yamada, et al.
Clinical Genitourinary Cancer|May 25, 2013
Metabolic syndrome as a peculiar target for management of prostate cancer patientsVincenza Conteduca, Giuseppe Di Lorenzo, Giovanni Bozza, et al.
International Journal of Oncology|November 21, 2012
H. pylori infection and gastric cancer: state of the art (review)Vincenza Conteduca, Domenico Sansonno, Gianfranco Lauletta, et al.
Journal of Visualized Experiments : Jove|December 30, 2017
Serum and Plasma Copy Number Detection Using Real-time PCRSamanta Salvi, Vincenza Conteduca, Filippo Martignano, et al.
The Oncologist|February 16, 2012
Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trialDomenico Sansonno, Gianfranco Lauletta, Sabino Russi, et al.
Future Oncology (London, England)|August 29, 2013
Circulating tumor cells: utopia or reality?Vincenza Conteduca, Rita Zamarchi, Elisabetta Rossi, et al.
Medicine|August 29, 2013
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective StudyGianfranco Lauletta, Sabino Russi, Vincenza Conteduca, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
The Role of Homologous Recombination Deficiency (HRD) in Renal Cell Carcinoma (RCC): Biology, Biomarkers, and Therapeutic OpportunitiesAlberto Bongiovanni, Pierfranco Conte, Vincenza Conteduca, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2016
Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinomaAlberto Farolfi, Giuseppe Schepisi, Vincenza Conteduca, et al.
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
Cells|January 22, 2021
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate CancerVincenza Conteduca, Alessandra Mosca, Nicole Brighi, et al.
Translational Andrology and Urology|August 25, 2021
Epigenetics in prostate cancer: clinical implicationsVincenza Conteduca, Judy Hess, Yasutaka Yamada, et al.
Clinical Genitourinary Cancer|May 25, 2013
Metabolic syndrome as a peculiar target for management of prostate cancer patientsVincenza Conteduca, Giuseppe Di Lorenzo, Giovanni Bozza, et al.
International Journal of Oncology|November 21, 2012
H. pylori infection and gastric cancer: state of the art (review)Vincenza Conteduca, Domenico Sansonno, Gianfranco Lauletta, et al.
Journal of Visualized Experiments : Jove|December 30, 2017
Serum and Plasma Copy Number Detection Using Real-time PCRSamanta Salvi, Vincenza Conteduca, Filippo Martignano, et al.
The Oncologist|February 16, 2012
Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trialDomenico Sansonno, Gianfranco Lauletta, Sabino Russi, et al.
Future Oncology (London, England)|August 29, 2013
Circulating tumor cells: utopia or reality?Vincenza Conteduca, Rita Zamarchi, Elisabetta Rossi, et al.
Medicine|August 29, 2013
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective StudyGianfranco Lauletta, Sabino Russi, Vincenza Conteduca, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
The Role of Homologous Recombination Deficiency (HRD) in Renal Cell Carcinoma (RCC): Biology, Biomarkers, and Therapeutic OpportunitiesAlberto Bongiovanni, Pierfranco Conte, Vincenza Conteduca, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2016
Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinomaAlberto Farolfi, Giuseppe Schepisi, Vincenza Conteduca, et al.
Pageof 16